Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
Saar I. Gill, MD, PhD

Saar I. Gill, MD, PhD Physician

Scientific Co-Director, Cell Therapy and Transplant Program Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Gill is employed by Penn Medicine.

Call 800-789-7366 Request a Callback
No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients in a medical practice setting.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.
X

Clinical Specialties

Clinical Expertise:

  • Acute Lymphocytic Leukemia
  • Acute Myelogenous Leukemia
  • Acute Promyelocytic Leukemia
  • Blood Cancer
  • Bone Marrow Biopsy
  • Chronic Lymphocytic Leukemia
  • Chronic Myelocytic Leukemia
  • Chronic Myelomonocytic Leukemia
  • Graft Versus Host Disease
  • Hairy Cell Leukemia
  • Hematologic Malignancies
  • Immunotherapy
  • Large Granular Lymphocytic Leukemia
  • Prolymphocytic Leukemia
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oscar Health Plan of PA
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: University of Melbourne
Residency: St. Vincent's Hospital Melbourne
Residency: St. Vincent Hospital
Residency: St. Vincent's Hospital
Fellowship: Peter MacCallum Cancer Centre
Fellowship: Hospital of the University of Pennsylvania

Memberships

American Society of Blood and Marrow Transplantation, International American Society of Gene & Cell Therapy, International American Society of Hematology (ASH) Scholar Study Section, National American Society of Hematology, International American Society of Hematology, International American Society of Transplant and Cell Therapy, International

Hospital Affiliation

Dr. Gill is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Tumor Immunology
Chimeric Antigen Receptor T cells
Mouse Models of Human Leukemia
Murine Xenografts
Adoptive Cellular Therapy
Genetic Engineering of T cells
Flow Cytometry

Selected Publications:

Saar Gill: How close are we to CAR T-cell therapy for AML? Best Pract Res Clin Haematol : 2019.

Duell Johannes, Lammers Philip E, Djuretic Ivana, Chunyk Allison G, Alekar Shilpa, Jacobs Ira, Gill Saar: Bispecific Antibodies in the Treatment of Hematologic Malignancies. Clinical pharmacology and therapeutics 106 (4): 781-791,2019.

Cummins Katherine D, Gill Saar: Chimeric antigen receptor T-cell therapy for acute myeloid leukemia: how close to reality? Haematologica 104 (7): 1302-1308,2019.

Kansagra Ankit J, Frey Noelle V, Bar Merav, Laetsch Theodore W, Carpenter Paul A, Savani Bipin N, Heslop Helen E, Bollard Catherine M, Komanduri Krishna V, Gastineau Dennis A, Chabannon Christian, Perales Miguel A, Hudecek Michael, Aljurf Mahmoud, Andritsos Leslie, Barrett John A, Bachanova Veronika, Bonini Chiara, Ghobadi Armin, Gill Saar I, Hill Joshua A, Kenderian Saad, Kebriaei Partow, Nagler Arnon, Maloney David, Liu Hien D, Shah Nirali N, Kharfan-Dabaja Mohamed A, Shpall Elizabeth J, Mufti Ghulam J, Johnston Laura, Jacoby Elad, Bazarbachi Ali, DiPersio John F, Pavletic Steven Z, Porter David L, Grupp Stephan A, Sadelain Michel, Litzow Mark R, Mohty Mohamad, Hashmi Shahrukh K: Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT). Bone marrow transplantation : 2019.

Ganetsky Alex, Han Jennifer H, Hughes Mitchell E, Babushok Daria V, Frey Noelle V, Gill Saar I, Hexner Elizabeth O, Loren Alison W, Luger Selina M, Mangan James K, Martin Mary Ellen, Smith Jacqueline, Freyer Craig W, Gilmar Cheryl, Schuster Mindy, Stadtmauer Edward A, Porter David L: Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 68 (12): 2003-2009,2019.

Cummins Katherine D, Gill Saar: Will CAR T cell therapy have a role in AML? Promises and pitfalls. Seminars in hematology 56 (2): 155-163,2019.

Petty Nicholas E, Gill Saar I: 21 Century FOX: Toward Gene Therapy for the Regulatory T Cell Deficiency Syndrome IPEX. Cell stem cell 24 (2): 208-209,2019.

Kansagra Ankit J, Frey Noelle V, Bar Merav, Laetsch Theodore W, Carpenter Paul A, Savani Bipin N, Heslop Helen E, Bollard Catherine M, Komanduri Krishna V, Gastineau Dennis A, Chabannon Christian, Perales Miguel A, Hudecek Michael, Aljurf Mahmoud, Andritsos Leslie, Barrett John A, Bachanova Veronika, Bonini Chiara, Ghobadi Armin, Gill Saar I, Hill Joshua, Kenderian Saad, Kebriaei Partow, Nagler Arnon, Maloney David, Liu Hien D, Shah Nirali N, Kharfan-Dabaja Mohamed A, Shpall Elizabeth J, Mufti Ghulam J, Johnston Laura, Jacoby Elad, Bazarbachi Ali, DiPersio John F, Pavletic Steven Z, Porter David L, Grupp Stephan A, Sadelain Michel, Litzow Mark R, Mohty Mohamad, Hashmi Shahrukh K: Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 25 (3): e76-e85,2019.

Ruella M, Barrett DM, Shestova O, Perazzelli J, Posey AD, Hong SJ, Kozlowski M, Lacey SF, Melenhorst JJ, June CH, Gill S: A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor positive cells Blood : 2019.

Frey NV, Shaw PA, Hexner EO, Pequignot E, Gill S, Luger SM, Mangan JK, Loren AW, Perl AE, Maude SL, Grupp SA, Shah NN, Gilmore J, Lacey SF, Melenhorst JJ, Levine BL, June CH, Porter DL: Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia Journal of Clinical Oncology : 2019.

Academic Contact Info

Room 8-101
Smilow Translational Research Center
3400 Civic Center Blvd

Philadelphia, PA 19104
Phone: (215) 573-4015
Patient appointments: 800-789-7366 (PENN)